US Patent 8703203 Oral dosage form of deferasirox
Patent 8703203 was granted and assigned to Ratiopharm on April, 2014 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 7, 2011
0
Date of Patent
April 22, 2014
0
Patent Application Number
13807738
0
Patent Inventor Names
Katrin Rimkus
0
Jana Paetz
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8703203 Oral dosage form of deferasirox
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.